|
Neuroone Medical Technologies Corp (NASDAQ: NMTC) |
|
Neuroone Medical Technologies Corp
NMTC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Neuroone Medical Technologies growth rates, revenue grew
by 31.1 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 98
Medical Equipment & Supplies industry recorded
growth of revenues by 2.43 %
Neuroone Medical Technologies net loss decreased from $-3 millions, to $-3 millions in III. Quarter 2024,
• More on NMTC's Growth
|
|
Neuroone Medical Technologies realized a net loss in trailing twelve months.
Neuroone Medical Technologies realized cash reduction of $ -0.05 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.83.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.77.
• More on NMTC's Valuation
|
|
|
|
|
Neuroone Medical Technologies realized net loss in trailing twelve months.
Neuroone Medical Technologies realized cash outflow of $ -0.05per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 6.83.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.77.
Neuroone Medical Technologies Price to Book Ratio is at 8.9 higher than Industry Avg. of -180.01, and higher than S&P 500 Avg. of 0.01
• More on NMTC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com